Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients
Clinical trial NCT02642913 · COMPLETED
Trial details
- NCT number
- NCT02642913
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2021-03-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.